{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:44:26Z","timestamp":1782603866391,"version":"3.54.5"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.562142","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:58:17Z","timestamp":1602658697000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic"],"prefix":"10.3389","volume":"7","author":[{"given":"Martin H.","family":"Stradner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth D.","family":"Fritsch-Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019 of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.coviro.2014.01.010","article-title":"MERS: emergence of a novel human coronavirus","volume":"5","author":"Raj","year":"2014","journal-title":"Curr Opin Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamainternmed.2020.2033","article-title":"Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"180","author":"Liang","year":"2020","journal-title":"JAMA Int Med."},{"key":"B13","volume-title":"Situation Report - 180","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.ijantimicag.2020.105948","article-title":"Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence","volume":"2020","author":"Wang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, china","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA."},{"key":"B20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042655","article-title":"COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome","author":"Zhang","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","article-title":"Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing","volume":"6","author":"Wen","year":"2020","journal-title":"Cell Discov."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.004655","article-title":"SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems","author":"Blanco-Melo","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","article-title":"Type I IFN immunoprofiling in COVID-19 patients","volume":"146","author":"Trouillet-Assant","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"medRxiv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.12.945576","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","author":"Zhou","year":"2020","journal-title":"bioRxiv [Preprint]"},{"key":"B28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3899\/jrheum.150671","article-title":"Risk of serious infection for patients with systemic lupus erythematosus starting glucocorticoids with or without antimalarials","volume":"43","author":"Herrinton","year":"2016","journal-title":"J Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semarthrit.2017.01.010","article-title":"Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus","volume":"47","author":"Rua-Figueroa","year":"2017","journal-title":"Semin Arthritis Rheum."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin Drug Saf."},{"key":"B32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/annrheumdis-2019-216102","article-title":"Comparative risk of serious infections among real-world users of biologics for psoriasis or psoriatic arthritis","volume":"79","author":"Li","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2016.11.006","article-title":"JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa","volume":"188","author":"Boor","year":"2017","journal-title":"Transl Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","article-title":"A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.23913","article-title":"Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis","volume":"59","author":"Lacaille","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/art.39849","article-title":"Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications","volume":"69","author":"Feldman","year":"2017","journal-title":"Arthr Rheumatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle east respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet."},{"key":"B40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/lt.25756","article-title":"Coronaviruses and immunosuppressed patients: the facts during the third epidemic","volume":"26","author":"D'Antiga","year":"2020","journal-title":"Liver Transplant"},{"key":"B41","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1086\/498875","article-title":"Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan","volume":"193","author":"Chang","year":"2006","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1542\/peds.2015-0950","article-title":"Concurrent respiratory viruses and kawasaki disease","volume":"136","author":"Turnier","year":"2015","journal-title":"Pediatrics."},{"key":"B43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1046\/j.1365-2141.2003.04608.x","article-title":"Severe acute respiratory syndrome and lupus anticoagulants in children","volume":"123","author":"Chow","year":"2003","journal-title":"Br J Haematol."},{"key":"B44","unstructured":"ChinaCDC WeeklyVital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)\u2014China2020"},{"key":"B45","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1017\/S0950268820001405","article-title":"Mortality and survival of COVID-19","volume":"148","author":"Sousa","year":"2020","journal-title":"Epidemiol Infect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/annrheumdis-2020-217424","article-title":"Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies","volume":"79","author":"Monti","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","volume":"71","author":"Williamson","year":"2020","journal-title":"Nature."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with covid-19 in washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/annrheumdis-2020-217903","article-title":"Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study","volume":"79","author":"Salvarani","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.semarthrit.2020.05.001","article-title":"Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs","volume":"50","author":"Michelena","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1101\/2020.05.11.20097808","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e549","DOI":"10.1016\/S2665-9913(20)30169-7","article-title":"COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case & control study","volume":"2","author":"Fredi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"217888","DOI":"10.1136\/annrheumdis-2020-217888","article-title":"Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US \u2018hot spot\u2019","volume":"2020","author":"D'Silva","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"217627","DOI":"10.1136\/annrheumdis-2020-217627","article-title":"Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China","volume":"2020","author":"Ye","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"218183","DOI":"10.1136\/annrheumdis-2020-218183","article-title":"Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China \u2018hot spot\u2019 versus in US \u2018hot spot\u2019: similarities and differences","volume":"2020","author":"Zhao","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases \u2014 case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"217690","DOI":"10.1136\/annrheumdis-2020-217690","article-title":"Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19","volume":"2020","author":"Konig","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"217566","DOI":"10.1136\/annrheumdis-2020-217875","article-title":"Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine","volume":"2020","author":"Mathian","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"217717","DOI":"10.1136\/annrheumdis-2020-218193","article-title":"COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine","volume":"2020","author":"Bozzalla Cassione","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"200507","DOI":"10.3899\/jrheum.200507","article-title":"Incidence and clinical course of covid-19 in patients with connective tissue diseases: a descriptive observational analysis","volume":"2020","author":"Favalli","year":"","journal-title":"J Rheumatol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"218244","DOI":"10.1136\/annrheumdis-2020-218244","article-title":"Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments","volume":"2020","author":"Gendebien","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217990","article-title":"Patients with systemic lupus erythematosus using hydroxychloroquine or chloroquine develop severe COVID-19 at similar frequency as patients not on antimalarials: need to explore antithrombotic benefits for COVID-19 coagulopathy. Response to: \u2018Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine\u2019 by Carbillon et al","author":"Konig","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"217794","DOI":"10.1136\/annrheumdis-2020-217794","article-title":"Patients with lupus with COVID-19: University of Michigan experience","volume":"2020","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"218068","DOI":"10.1136\/annrheumdis-2020-218068","article-title":"Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients","volume":"2020","author":"Favalli","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26286","article-title":"Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection","author":"Ferreira","year":"2020","journal-title":"J Med Virol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00296-020-04584-7","article-title":"Coronavirus disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs","volume":"40","author":"Song","year":"2020","journal-title":"Rheumatol Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"217362","DOI":"10.1136\/annrheumdis-2020-218147","article-title":"Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept","volume":"2020","author":"Duret","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jiac.2020.06.022","article-title":"Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide","volume":"26","author":"Baba","year":"2020","journal-title":"J Infect Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10067-020-05234-w","article-title":"A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab","volume":"2020","author":"Cai","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.3346\/jkms.2020.35.e201","article-title":"Olfactory and gustatory dysfunction in a covid-19 patient with ankylosing spondylitis treated with etanercept: case report","volume":"35","author":"Lee","year":"2020","journal-title":"J Korean Med Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e13708","DOI":"10.1111\/dth.13708","article-title":"Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab","author":"Valenti","year":"2020","journal-title":"Dermatol Ther."},{"key":"B76","doi-asserted-by":"publisher","first-page":"218075","DOI":"10.1136\/annrheumdis-2020-218075","article-title":"Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab","volume":"2020","author":"Schulze-Koops","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218171","article-title":"COVID-19 in patients with rheumatological diseases treated with anti-TNF","author":"Brito","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.05.003","article-title":"Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy","author":"Quartuccio","year":"2020","journal-title":"Joint Bone Spine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e13961","DOI":"10.1111\/dth.13961","article-title":"COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain","author":"Queiro Silva","year":"2020","journal-title":"Dermatol Ther"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1007\/s10067-020-05160-x","article-title":"COVID-19 with rheumatic diseases: a report of 5 cases","volume":"39","author":"Cheng","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/art.41388","article-title":"Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?","author":"Favalli","year":"2020","journal-title":"Arthr Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/annrheumdis-2020-217948","article-title":"Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies","volume":"79","author":"Sanchez-Piedra","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/annrheumdis-2020-217442","article-title":"COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD","volume":"79","author":"Mihai","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"217864","DOI":"10.1136\/annrheumdis-2020-217864","article-title":"Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab","volume":"2020","author":"Avouac","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217549","article-title":"Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia","author":"Guilpain","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"217600","DOI":"10.1136\/annrheumdis-2020-217600","article-title":"Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey","volume":"2020","author":"Tomelleri","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B87","doi-asserted-by":"publisher","first-page":"108413","DOI":"10.1016\/j.clim.2020.108413","article-title":"COVID-19 in a patient with long-term use of glucocorticoids: a study of a familial cluster","volume":"214","author":"Han","year":"2020","journal-title":"Clin Immunol."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.06.002","article-title":"Leptomeningeal involvement in a patient with systemic lupus erythematosus infected by COVID-19","author":"Guven","year":"2020","journal-title":"Joint Bone Spine."},{"key":"B89","doi-asserted-by":"publisher","first-page":"217665","DOI":"10.1136\/annrheumdis-2020-217665","article-title":"No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: response to the comment by Joob and Wiwanitkit","volume":"2020","author":"Rom\u00e3o","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1016\/S2665-9913(20)30161-2","article-title":"COVID-19 and systemic lupus erythematosus: a case series","volume":"2","author":"Gartshteyn","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"102502","DOI":"10.1016\/j.jaut.2020.102502","article-title":"SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 atients","volume":"2020","author":"Zen","year":"2020","journal-title":"J Autoimmun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"217787","DOI":"10.1136\/annrheumdis-2020-217787","article-title":"Are patients with systemic lupus erythematosus at increased risk for COVID-19?","volume":"2020","author":"Favalli","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"217919","DOI":"10.1136\/annrheumdis-2020-217919","article-title":"Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak","volume":"2020","author":"Holubar","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"108410","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","volume":"215","author":"Sawalha","year":"2020","journal-title":"Clin Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost."},{"key":"B97","doi-asserted-by":"publisher","first-page":"704395","DOI":"10.1155\/2014\/704395","article-title":"Isolated IgA anti- beta2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome","volume":"2014","author":"Ruiz-Garcia","year":"2014","journal-title":"J Immunol Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/art.38131","article-title":"Value of isolated IgA anti-beta2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome","volume":"65","author":"Murthy","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B100","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N Engl J Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"2020","author":"Helms","year":"2020","journal-title":"Intens Care Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.17.20134114","article-title":"Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?","author":"Borghi","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/art.41425","article-title":"Brief report: anti-phospholipid antibodies in critically ill patients with Coronavirus Disease 2019 (COVID-19)","author":"Xiao","year":"2020","journal-title":"Arthr Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.15.20131607","article-title":"Prothrombotic antiphospholipid antibodies in COVID-19","author":"Zuo","year":"2020","journal-title":"medRxiv [Preprint]."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1177\/0961203316640912","article-title":"Systematic review of case reports of antiphospholipid syndrome following infection","volume":"25","author":"Abdel-Wahab","year":"2016","journal-title":"Lupus."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13075-019-1977-9","article-title":"Respiratory viral infections and the risk of rheumatoid arthritis","volume":"21","author":"Joo","year":"2019","journal-title":"Arthritis Res Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and kawasaki disease: novel virus and novel case","volume":"10","author":"Jones","year":"2020","journal-title":"Hospital Pediatr"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in New York state","volume":"383","author":"Dufort","year":"2020","journal-title":"N Engl J Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. Children and Adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","volume":"395","author":"Verdoni","year":"2020","journal-title":"Lancet."},{"key":"B113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","article-title":"Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2","volume":"324","author":"Whittaker","year":"2020","journal-title":"JAMA."},{"key":"B114","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/annrheumdis-2020-217960","article-title":"Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort","volume":"79","author":"Pouletty","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: a meta-analysis","author":"Aziz","year":"2020","journal-title":"J Med Virol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11684-019-0714-8","article-title":"Management of cytokine release syndrome related to CAR-T cell therapy","volume":"13","author":"Chen","year":"2019","journal-title":"Front Med."},{"key":"B117","first-page":"143","article-title":"Vademecum for the treatment of people with COVID-19","volume":"28","author":"Tropical","year":"2020","journal-title":"Infez Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"102568","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"2020","author":"Toniati","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B119","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B120","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejim.2020.05.021","article-title":"Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study","volume":"76","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"102511","DOI":"10.1016\/j.jaut.2020.102511","article-title":"Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: a retrospective case-control survival analysis of 128 patients","volume":"2020","author":"Canziani","year":"2020","journal-title":"J Autoimmun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218243","article-title":"Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study","author":"Potere","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/qjmed\/hcaa206","article-title":"Outcomes in patients with severe COVID-19 disease treated with tocilizumab - a case- controlled study","volume":"113","author":"Rojas-Marte","year":"2020","journal-title":"QJM."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.29.20117358","article-title":"Tocilizumab for treatment of mechanically ventilated patients with COVID-19","author":"Somers","year":"2020","journal-title":"medrxiv [Preprint]"},{"key":"B127","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.jaut.2020.102512","article-title":"Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab","volume":"2020","author":"Morrison","year":"2020","journal-title":"J Autoimmun"},{"key":"B128","first-page":"529","article-title":"Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19","volume":"38","author":"Sciascia","year":"2020","journal-title":"Clin Exp Rheumatol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.chest.2020.04.024","article-title":"Use of tocilizumab for covid-19-induced cytokine release syndrome: a cautionary case report","volume":"158","author":"Radbel","year":"2020","journal-title":"Chest."},{"key":"B130","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13054-018-2012-2","article-title":"Diagnostic and management of life-threatening adult-onset still disease: a French nationwide multicenter study and systematic literature review","volume":"22","author":"Neel","year":"2018","journal-title":"Crit Care."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/annrheumdis-2020-217706","article-title":"Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series","volume":"79","author":"Aouba","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/art.41422","article-title":"Use of anakinra to prevent mechanical ventilation in severe covid-19: a case series","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"Arthr Rheumatol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"416","DOI":"10.5694\/mja2.50577","article-title":"Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)","volume":"212","author":"Zha","year":"2020","journal-title":"Med J Aust"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19 - preliminary report","author":"Horby","year":"2020","journal-title":"N Engl J Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1196\/annals.1321.004","article-title":"Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS","volume":"1024","author":"Meduri","year":"2004","journal-title":"Ann N Y Acad Sci."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2024638","article-title":"Research in the context of a pandemic","author":"Lane","year":"2020","journal-title":"N Engl J Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e109180","DOI":"10.1371\/journal.pone.0109180","article-title":"Chloroquine is a zinc ionophore","volume":"9","author":"Xue","year":"2014","journal-title":"PLoS ONE."},{"key":"B139","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir Chem Chemother."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.22.20040758","article-title":"Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial","author":"Chen","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B141","doi-asserted-by":"publisher","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study","volume":"2020","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with covid-19 in New York state","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19","author":"Magagnoli","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B146","doi-asserted-by":"publisher","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Full-length title: early treatment of covid-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in marseille, france","volume":"35","author":"Million","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12471-020-01429-7","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","volume":"2020","author":"van den Broek","year":"2020","journal-title":"Neth Heart J"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e201787","DOI":"10.1001\/jamacardio.2020.1787","article-title":"Assessment of QT Intervals in a case series of patients with coronavirus disease 2019 (Covid-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","volume":"1","author":"Bessiere","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B150","unstructured":"2020"},{"key":"B151","unstructured":"SwankF\n          FDA2020"},{"key":"B152","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet."},{"key":"B153","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jinf.2020.06.052","article-title":"Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study","volume":"81","author":"Cantini","year":"2020","journal-title":"J Infect."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1007\/s10067-020-05247-5","article-title":"Colchicine as a possible therapeutic option in COVID-19 infection","volume":"39","author":"Parra-Medina","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e2013136","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the grecco-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B156","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2217\/imt-2020-0095","article-title":"Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens","volume":"12","author":"D\u00edez","year":"2020","journal-title":"Immunotherapy."},{"key":"B157","doi-asserted-by":"publisher","first-page":"ofaa102","DOI":"10.1093\/ofid\/ofaa102","article-title":"High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with coronavirus disease 2019","volume":"7","author":"Cao","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","article-title":"Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19","volume":"81","author":"Xie","year":"2020","journal-title":"J Infect."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2020.05.006","article-title":"Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: a case series","volume":"548","author":"Mohtadi","year":"2020","journal-title":"Virology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.562142\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T06:58:24Z","timestamp":1602658704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmed.2020.562142\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":159,"alternative-id":["10.3389\/fmed.2020.562142"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.562142","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"article-number":"562142"}}